NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
10 avr. 2024 09h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
09 avr. 2024 09h05 HE
|
NeuroOne Medical Technologies Corp
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE,...
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
04 avr. 2024 09h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
26 mars 2024 09h00 HE
|
NeuroOne Medical Technologies Corp
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control Limited...
NeuroOne® to Participate in the 36th Annual Roth Conference
08 mars 2024 12h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23 févr. 2024 17h10 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
13 févr. 2024 16h00 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
08 févr. 2024 15h30 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update
14 déc. 2023 16h15 HE
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Dec. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System
11 déc. 2023 08h00 HE
|
NeuroOne Medical Technologies Corp
First FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control; Marks the Company’s third...